395 reports of this reaction
1.9% of all CAPTOPRIL reports
#10 most reported adverse reaction
VOMITING is the #10 most commonly reported adverse reaction for CAPTOPRIL, manufactured by AMICI PHARMACEUTICALS LLC. There are 395 FDA adverse event reports linking CAPTOPRIL to VOMITING. This represents approximately 1.9% of all 21,001 adverse event reports for this drug.
Patients taking CAPTOPRIL who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VOMITING is a less commonly reported adverse event for CAPTOPRIL, but still significant enough to appear in the safety profile.
In addition to vomiting, the following adverse reactions have been reported for CAPTOPRIL:
The following drugs have also been linked to vomiting in FDA adverse event reports:
VOMITING has been reported as an adverse event in 395 FDA reports for CAPTOPRIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
VOMITING accounts for approximately 1.9% of all adverse event reports for CAPTOPRIL, making it a notable side effect.
If you experience vomiting while taking CAPTOPRIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.